A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as pa...
BOSTON - A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication.
The plea deal was announced on Wednesday, a month after a federal jury found wealthy Insys founder John Kapoor and four other former executives and managers guilty of engaging in a vast racketeering conspiracy. U.S. District Judge Rya Zobel approved the parent company’s deferred prosecution agreement at Friday’s hearing and scheduled sentencing for the subsidiary for July 10.
Prosecutors alleged that while Kapoor served as Insys’ chairman, the company from 2012 to 2015 paid doctors and other medical practitioners bribes in exchange for prescribing Subsys to their patients, often to those who did not have cancer.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Unit of drugmaker Insys to plead guilty to U.S. opioid bribe schemeA unit of Insys Therapeutics Inc is set to plead guilty on Friday to fraud charg...
Read more »
Opioid manufacturer agrees to pay $225 million to settle corruption caseAn opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell fentanyl spray
Read more »
Opioid manufacturer agrees to pay $225M to settle criminal and civil investigationsOpioid manufacturer Insys Therapeutics agrees to pay a $225 million settlement to resolve federal government's criminal and civil investigations into the company's illegal marketing of a powerful but highly-addictive painkiller, prosecutors say.
Read more »
Opioid maker agrees to pay $225M to settle federal probesAn opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell a powerful fentanyl spray, authorities said Wednesday. The settlement stems from criminal and civil probes into Insys Therapeutics
Read more »